Media Thread, page-6119

Hi Sagitarius,

Incase the wise Owl is tied up, I’ll give it a crack. Antibody conjugates are basically monoclonal antibodies, like Herceptin and Keytruda. So still synthetic, albeit more specific cancer fighting than say chemo.

IMUs polyclonal antibody vaccines are the more cutting edge. And with our mimotope platform any monoclonal/antibody conjugate they come up with we can use the same target and have the patients body create the antibodies themselves.

The human body is much better at doing this than humans, hence the reason adverse effects are low and efficacy high, relatively.

Open to other thoughts of course.